varios testes

Two Dozen-Plus Biotechs Went Public This Year—With More In The Works

·

coisa
In this week’s edition of InnovationRx, the bumper crop of biotech IPOs, Isomorphic’s reported $40 billion valuation fundraise, and the impact of drugmakers’ gifts to doctors.

Comments

Deixe um comentário

O seu endereço de e-mail não será publicado. Campos obrigatórios são marcados com *